MedPath

tility of MUC1 in breast carcinoma with clinicopathological parameters, tumor characteristics and hormone receptors.

Not Applicable
Conditions
Health Condition 1: C50- Malignant neoplasm of breast
Registration Number
CTRI/2021/02/031221
Lead Sponsor
Rohilkhand Medical College Bareilly
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All types of breast carcinomabiopsy specimens received in the Pathology Department of Rohilkhand Medical College & Hospital, Bareilly.

2.Cases with complete details like age, sex, histological diagnosis, tumour grade and lymphovascular invasion and other clinical parameters.

Exclusion Criteria

1.Inadequate samples.

2.Improper records and slides.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
study MUC1 expression in breast carcinoma as a prognostic marker and correlate with clinico-pathological parameters, tumor characteristics and hormone receptors.Timepoint: Nil
Secondary Outcome Measures
NameTimeMethod
correlate the expression of MUC1 in breast carcinoma with the clinico-pathological parameters, characteristics of the tumor and expression of the hormone receptors.Timepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath